What Happened?
Shares of healthcare technology company GE HealthCare Technologies (NASDAQ: GEHC) jumped 2.8% in the afternoon session after the company announced a new distribution agreement for its cardiac imaging agent and received FDA clearance for an innovative CT imaging system.
The healthcare technology firm partnered with CardioNavix to expand the U.S. distribution of its cardiac PET imaging agent, Flyrcado, aiming to increase its availability in private cardiology practices and outpatient settings. This move is expected to broaden the reach of cardiac PET imaging for evaluating coronary artery disease. Adding to the positive sentiment, GE HealthCare also received FDA 510(k) clearance for its Revolution Vibe CT system. This new device is designed to handle difficult cardiac exams, utilizing integrated AI-powered tools to provide a fast, non-invasive method for identifying potential heart blockages, thereby enhancing the company's offerings in cardiac care.
After the initial pop the shares cooled down to $78.05, up 3% from previous close.
Is now the time to buy GE HealthCare? Access our full analysis report here, it’s free.
What Is The Market Telling Us
GE HealthCare’s shares are not very volatile and have only had 7 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful, although it might not be something that would fundamentally change its perception of the business.
The previous big move we wrote about was 17 days ago when the stock gained 3.2% on the news that the major indices rebounded, as Fed Chair Jerome Powell delivered dovish remarks at the much-awaited Jackson Hole symposium. Powell suggested that with inflation risks moderating and unemployment remaining low, the Federal Reserve might consider a shift in its monetary policy stance, including potential interest rate cuts. This outlook eased market concerns about prolonged high interest rates and their impact on economic growth. The prospect of lower borrowing costs bolstered investor confidence, particularly in sectors that have lagged, leading to a broad rally across the market.
GE HealthCare is down 0.4% since the beginning of the year, and at $78.05 per share, it is trading 16.8% below its 52-week high of $93.85 from September 2024.
Unless you’ve been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story.
